Using Syndromic Surveillance to Identify Synthetic Cannabinoids or Marijuana Adverse Health Events in Virginia
Author(s) -
Amanda Wahnich
Publication year - 2016
Publication title -
online journal of public health informatics
Language(s) - English
Resource type - Journals
ISSN - 1947-2579
DOI - 10.5210/ojphi.v8i1.6491
Subject(s) - medicine , public health , emergency department , legalization , synthetic cannabinoids , adverse effect , medical emergency , cannabis , environmental health , public health surveillance , cannabinoid , family medicine , psychiatry , pharmacology , nursing , receptor
Public health reports from poison control center calls and emergency department visits, as well as circulating media reports, indicate an increase in adverse health events from synthetic cannabinoids throughout the country. Legal action varies in effectiveness to ban these products and discontinue sales. Increasing reports of clusters of cannabinoid related health effects and statewide marijuana legalization on the horizon highlight the importance of utilizing syndromic surveillance to monitor and characterize morbidity associated with these products.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom